For example, pooled data from randomized controlled trials indicate that GLP-1 RAs can reduce AHI by approximately 5–16 events per hour, with greater improvements observed in individuals with higher baseline obesity (101, 102). This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.